In the dark path of tumorigenesis, the more carefully the cancer biology is studied, the more
brilliant answers could be given to the countless questions about its orchestrating derivers …

Bladder cancer is one of the leading causes of death worldwide. The main immune
mechanisms which lead to bladder cancer development or treatment outcomes have yet to …

ABSTRACT The Bacillus Calmette–Guérin (BCG) vaccine is the oldest cancer
immunotherapeutic agent in use. Despite its effectiveness, its initial mechanisms of action …

Patients with bladder cancer (BLCA) still show high recurrence after surgery and
chemotherapy. Hesperetin (HE), as a natural compound, has attracted researchers' attention …

The treatment strategy of bladder cancer has evolved not only through the traditional
modalities of surgery and chemotherapy but also by immunotherapy over the past several …

MicroRNAs, as a major type of noncoding RNAs, have crucial roles in various functions
during development. Available data have shown that miR-542-3p decreased in various …

Emerging evidence has uncovered critical regulatory roles of circular RNAs (circRNAs)
function as dynamic scaffolding molecules in tumorigenesis and progression. However, the …

Background Immunotherapy has shown promising results in bladder cancer therapy options.
Methods Analysis of open-access data was conducted using the R software. Open-access …

This study assessed the safety and efficacy of OncoTherad®(MRB-CFI-1)
nanoimmunotherapy for non-muscle invasive bladder cancer (NMIBC) patients …

There is a critical unmet clinical need for bladder cancer immunotherapies capable of
inducing durable antitumor immunity. We have shown that four intravesical treatments with a …